首页 | 本学科首页   官方微博 | 高级检索  
     


Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology
Affiliation:1. Peter Doherty Institute for Infection and Immunity, Elizabeth Street, Melbourne, Victoria 3000, Australia;2. University of Melbourne, Grattan Street, Parkville, Victoria 3010, Australia;3. Olivia Newton John Cancer Research Institute, Austin Hospital, 145 Studley Road, Heidelberg, Victoria 3084, Australia;4. Royal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australia;5. National University of Singapore, 21 Lower Kent Ridge Road, Singapore 119077, Singapore;6. University of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australia;7. University of Queensland Oral Health Centre, 288 Herston Road, Queensland 4006, Australia;8. St Vincent’s Hospital, 41 Victoria Street, Fitzroy, Victoria 3065, Australia;9. University of California, San Francisco, S357 Parnassus Avenue, San Francisco, CA 94143, USA;10. Ingham Institute, 1 Campbell Street, Liverpool, Sydney, New South Wales 2170, Australia;11. Victorian Comprehensive Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australia;12. Department of Public Health, La Trobe University, Plenty Road, Bundoora, Victoria 3086, Australia;13. The Alfred and Monash University, 85 Commercial Road, Melbourne, Victoria 3004, Australia;14. Burnet Institute, 85 Commercial Road, Melbourne, Victoria 3004, Australia;15. Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA;1. Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Institut de Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Villarroel 170, Barcelona 08036, Spain;2. CIBEREHD (Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas), HealthCare Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver);1. Department of Medicine, Allergy and Clinical Immunology Section, University of Verona and Verona University Hospital, Piazzale Scuro 10, Verona 37134, Italy;2. Allergy and Respiratory Diseases, IRCCS Policlinico San Martino, University of Genoa, Largo Rosanna Benzi, 10, Genoa 16132, Italy;3. UMKC School of Medicine, Kansas City, MO, USA;4. Respiratory Pathophysiology Division, University of Padua, Padua, Italy;5. Dipartimento di Scienze CardioToraco Vascolari e Sanità Pubblica, Via Nicolo` Giustiniani, 2, Padua 35128, Italy;6. Department of Medicine, Allergy and Clinical Immunology School, University of Verona & Asthma Center and Allergy Unit, Verona University Hospital, Piazzale Scuro 10, Verona 37134, Italy;1. School of Public Health, University of Haifa, 199 Aba Khoushy Ave, Haifa 3498838, Israel;2. Liver Unit, Department of Gastroenterology, Tel-Aviv Medical Center, 6 Weizmann Street, Tel Aviv 6423906, Israel;3. Sackler Faculty of Medicine, Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel;4. Department of Anesthesiology and Pain Medicine, University of Washington, Harborview Medical Center, 325 Ninth Avenue, Seattle, WA 98104, USA
Abstract:
Keywords:Hepatitis B virus  Hepatitis B immunology  Innate  Adaptive  Reactivation  Prophylaxis
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号